Abstract
In Brief Objectives: We reviewed the long-term results of an acellular human dermal allograft (Repliform; Boston Scientific, Natick, MA) sling with transvaginal bone anchors for the treatment of stress urinary incontinence. Materials and Methods: A retrospective analysis was performed on 61 consecutive patients who underwent a transvaginal sling with an acellular human dermal allograft and transvaginal bone anchors for stress urinary incontinence. All procedures were performed by one surgeon (T.L.). Postoperatively, all patients received a questionnaire evaluating continence, pelvic pain, and satisfaction with the procedure. Patients who did not return the questionnaire were contacted by phone (if they could be located) and encouraged to participate. Results: Thirty-one of the 61 patients completed the questionnaire for a response rate of 51%. Follow up ranged from 14 to 63 months (mean, 33.5 months). Of the group that responded, 22.5% reported being completely dry and 70.9% reported incontinence with minimal to moderate activity. Forty-eight percent of patients report using one or more pads per day, whereas 19% never use a pad. Forty-five percent report being satisfied with the procedure. Fifty-one percent report that their urinary control is significantly better, whereas 9% report it is worse. No patient developed osteitis pubis but 4 (12.9%) developed dyspareunia. Conclusion: We conclude that the transvaginal sling with an acellular human dermal allograft and the use of bone anchors has poor long-term results as an antiincontinence procedure. The use of bone anchors did not seem to increase the risk of osseous complications. Long-term outcomes with a human dermal allograft sling with bone anchors are reviewed. At an average follow-up of 33.5 months 71% of patients experienced incontinence with minimal to moderate activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.